|Bid||41.58 x 900|
|Ask||43.91 x 1100|
|Day's Range||42.66 - 43.61|
|52 Week Range||19.41 - 46.52|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||26.76|
|Earnings Date||Jul 28, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||50.60|
CVS Health's (CVS) consumer-centric digital strategy is more relevant in the current environment as people are increasingly using technology while staying indoors.
Bruker (BRKR) updates 2021 financial guidance encouraged by solid business growth and high-growth opportunities.
Investors are optimistic about Bruker (BRKR) on solid CALID Group growth potential and raised 2021 financial guidance.